![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Novel and Potent HBV Capsid Modulator Reduces HBeAg and cccDNA
in Core-site Directed T109I Mutant in HepNTCP Cells
|
|
|
Dr Schinazi présents the structure which apparently is not generally done.br clear="all" />
Reported by Jules Levn
EASL 2018 april 11-15 Paris Francebr clear="all" />
Leda Bassit1, Bryan Cox1, Suzane K Ono2, Kiran Verma1, Jack Yoon1,
Franck Amblard1, and Raymond F Schinazi1*
1Center for AIDS Research, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. 2Department of Gastroenterology, University of São Paulo School of Medicine, Sao Paulo, Brazil.
![0420181](../images%20/042018/042018-16/0420181.gif)
![0420182](../images%20/042018/042018-16/0420182.gif)
![0420183](../images%20/042018/042018-16/0420183.gif)
![0420184](../images%20/042018/042018-16/0420184.gif)
![0420185](../images%20/042018/042018-16/0420185.gif)
![0420186](../images%20/042018/042018-16/0420186.gif)
![0420187](../images%20/042018/042018-16/0420187.gif)
![0420188](../images%20/042018/042018-16/0420188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|